Navigation Links
Local Head-Injury Patients Sought for Study Investigating Potential Treatment for Daytime Sleepiness
Date:1/12/2010

KING OF PRUSSIA, Pa., Jan. 12 /PRNewswire/ -- Local patients are being sought for a national clinical research study currently investigating a study medication for people who have had a head injury, concussion or bump on the head and feel sleepy or tired during the day.  According to the Centers for Disease Control and Prevention, head injury is one of the most common neurologic disorders, affecting around 1.5 million Americans every year. Many people with a past head injury feel sleepy during the day, yet few people know that their sleepiness might be connected to this injury.  People experiencing daytime sleepiness who have had one head injury within the last 10 years are encouraged to contact the clinical research screening center at 1-877-674-6317 or go to www.HeadInjuryResearchStudy.com for more information and where they can take the pre-screening questionnaire to see if they are eligible for the study.

"Currently, there are no treatments for patients who suffer from sleepiness during the day as a result of head injury," according to study investigator Dr. Milton Erman, MD at Avastra Clinical Trials. "Consequently, there is a great need for new medicines to treat this life-changing problem."

The clinical study is specifically designed for adults aged 18 to 65 who have had a head injury, concussion, or bump on the head within the last 10 years and feel sleepy or tired during the day. It will examine different dosage strengths of the study medicine and how patients respond to them. Eligible participants may receive medical care related to the study at no cost and be reimbursed for time and travel as a result of taking part in the trial.

A recent online survey of more than 100 people who have had a previous head injury found that feeling sleepy during the day negatively affects their work and family life. The survey was conducted by MediciGlobal, a patient communications firm working with Cephalon, Inc., the biopharmaceutical company sponsoring the study.

"Seventy percent of head injury sufferers surveyed said that their daytime sleepiness affects their ability to effectively interact with their family and co-workers, and seriously impacts long-term relationships," said Dr. Erman.  "This study is important because daytime sleepiness can negatively impact the daily lives of so many patients suffering from head injuries."

About the Study Sponsor

Founded in 1987, Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and commercialization of many unique products in four core therapeutic areas: central nervous system, inflammatory diseases, pain and oncology.

SOURCE MediciGlobal

RELATED LINKS
http://www.HeadInjuryResearchStudy.com

'/>"/>

SOURCE MediciGlobal
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Induction Chemotherapy Followed by ChemoRadiotherapy Increased Time-to-Treatment Failure Compared to ChemoRadiotherapy Alone in Patients With Unresectable Locally Advanced Head & Neck Cancer
2. Men Treated for Localized Prostate Cancer Could Benefit From Pomegranate Juice Consumption
3. Walter Reed Army Medical Center offers HIFU for Qualifying Men with Locally Recurrent Prostate Cancer in a Phase III Clinical Trial
4. Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
5. Local Research Foundation Achieves Milestone in Fight Against Cancer
6. Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants
7. High Intensity Focused Ultrasound for Locally Recurrent Prostate Cancer Following External Beam Radiation Therapy Investigated in Phase III Clinical Study
8. Journal of the American Dental Association Publishes Key Clinical Data for the Use of OraVerse(TM) a Local Anesthetic Reversal Agent
9. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
10. Banner Alzheimers Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
11. New Localized Cancer Treatment for Advanced Retinoblastoma Saves Children From Having Eyes Removed, Restores Vision in Some Cases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... April 27, 2016 Oasmia ... developer of a new generation of drugs within ... survival results for Paclical/Apealea in the Phase III ... with epithelial ovarian cancer. These preliminary results showed ... combination with carboplatin versus Taxol in combination with ...
(Date:4/27/2016)... 2016 At the Sachs CEO ... a Phase 2 clinical study of its lead drug ... cochlear implantation (CI) surgery. This large, placebo-controlled, double-blind, phase ... Germany and France . ... the time of surgery. "Despite advances in cochlear implant ...
(Date:4/26/2016)... 26, 2016 US demand for infection ... 4.9 percent annually to $27.6 billion in 2020.  ... to decrease rates of healthcare-associated infections (HAIs) will ... and services.  Although declining, the overall rate of ... levels set by the CDC.  Recent statistics indicate ...
Breaking Medicine Technology:
(Date:4/28/2016)... (PRWEB) , ... April 29, 2016 , ... Monthly subscription ... products on the market. They recently reviewed the ZEN BOX , the aromatherapy ... are two single essential oils (like lavender or frankincense) and one Zen Blend (like ...
(Date:4/28/2016)... ... April 28, 2016 , ... Sanford Health’s ... week. A group of researchers and leaders from Sanford Health were selected to ... and Its Cultural Impact ” and receive the 2016 Pontifical Key Innovation Award ...
(Date:4/28/2016)... ... 2016 , ... CastCoverz!, America’s #1 trusted brand for cast ... waterproof cast protector . As the largest one-stop, orthopedic shop, CastCoverz! offers ... night, weatherproof and waterproof covers for most orthopedic devices, including but not limited ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... announces today the open availability of a new CDISC standard, Clinical Trial ... registering clinical trials. This innovative standard will make it possible to build ...
(Date:4/28/2016)... ... April 28, 2016 , ... Trinity Health, one of ... leading force in the fight to reduce tobacco use and its deadly toll, ... help reduce tobacco use. The initiative brings together two organizations committed to achieving ...
Breaking Medicine News(10 mins):